About The ASCO Post
Rights and Permissions
In the Clinic
View By Issue
2019 Supportive Care in Oncology Symposium
ASCO Breakthrough: A Global Summit for Oncology Innovators
ESMO 2019 Congress
NCCN 2019 Annual Congress: Hematologic Malignancies
2019 ASTRO Annual Meeting
Biomarkers in Immunotherapy
IMPROVING NSCLC OUTCOMES
Methotrexate–Induced Kidney Injury
No results found for "Francis Paul Worden, MD"
Ensure words are spelled correctly.
Try rephrasing keywords or using synonyms.
Try less specific keywords.
Today In Oncology
High Conversion Rate With Certain Induction Chemotherapy Regimens is Associated With Improved OS in LAPC
AMG 510 for KRAS G12C–Mutated, Advanced NSCLC
FDA Pipeline: Advances in Prostate Cancer, Urothelial Cancer, Myelofibrosis, and More
3-Year Results From CheckMate 238: Adjuvant Nivolumab vs Ipilimumab in Advanced Melanoma
Complete Mesocolic Excision in Right-Sided Colon Cancer
Most Read Stories
Fallopian Tube Removal May Protect Premenopausal Women at High Risk for Ovarian Cancer From Some Surgical Side Effects
Nivolumab vs Chemotherapy in Previously Treated Advanced Esophageal Squamous Cell Carcinoma
When Can Patients With Gleason 6 Prostate Cancer Safely Undergo Active Surveillance?
Exercise for Patients With Cancer to Minimize Treatment Cardiotoxicity
Romiplostim for Patients With Chemotherapy-Induced Thrombocytopenia
© 2019 HSP News Service, L.L.C.